Tasisulam sodium (LY573636 sodium) as third-line treatment in patients with unresectable, metastatic non-small-cell lung cancer: a phase-II study.
J Thorac Oncol
; 7(6): 1053-7, 2012 Jun.
Article
in En
| MEDLINE
| ID: mdl-22588156
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sulfonamides
/
Benzamides
/
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
/
Neoplasm Staging
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
J Thorac Oncol
Year:
2012
Type:
Article
Affiliation country:
Italy